ClinicalTrials.govpublic full text
Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer
gastric cancer, g17dt, pas, insegia, gastrimmune, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 878733
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.